Skip to main content

Advertisement

SpringerLink
Log in

Chemokines: therapeutic targets for autoimmune and inflammatory renal disease

  • Original Paper
  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1.  Laboratory of Molecular Autoimmune Disease, Renal Division, Brigham and Women’s Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA, , , , , , US

    Vicki Rubin Kelley

  2.  The Ohio State University School of Medicine and Public Health, Renal Division, and the Dorothy M. Davis Heart and Lung Research Institute, Columbus, Ohio, USA, , , , , , US

    Brad H. Rovin

Authors
  1. Vicki Rubin Kelley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brad H. Rovin
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Acknowledgements. This work was supported by USPHS grants DK-36149 (V.R.K.), DK-52369 (V.R.K.), DK-56848 (V.R.K.), the Alliance for Lupus Research (V.R.K.) DK-55546 (B.H.R.), and DK-46055 (B.H.R.).

Correspondence to: V.R. Kelley

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kelley, V., Rovin, B. Chemokines: therapeutic targets for autoimmune and inflammatory renal disease. Springer Semin Immunopathol 24, 411–421 (2003). https://doi.org/10.1007/s00281-003-0124-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00281-003-0124-4

Keywords

Search

Navigation